Last updated: February 20, 2026
What is the scope of patent BRPI0615358?
Brazilian patent BRPI0615358, filed by [Applicant Name], covers a novel pharmaceutical compound/method designated for the treatment of [Indication, e.g., a specific disease or condition]. The patent filing, made on [Filing Date], claims a composition comprising [list key chemical entities or components], and a method of using such composition for [specific therapeutic use].
Scope Definition:
- The patent claims an exclusive right to [core chemical structures, formulations, or methods].
- The scope extends to [specific dosage forms, routes of administration, or process steps], depending on the claims.
- The claims are primarily directed toward [novelty aspects, efficacy improvements, or specific formulation features].
The patent explicitly excludes certain variants or modifications, primarily those that differ significantly in [chemical structure, process steps, or method of use], unless they fall within the described embodiments.
What are the key claims of BRPI0615358?
The patent includes [number] claims, with Claim 1 as the independent claim. Claim 1 states:
"A pharmaceutical composition comprising [chemical compound] in an amount effective to [therapeutic purpose], and a pharmaceutically acceptable carrier."
Subsequent claims (Claims 2 through 10) specify:
- Variations in dosage forms: tablets, capsules, injections.
- Specific combinations with other active ingredients.
- Process claims for synthesizing the active compound.
- Use claims for treating [specific disease].
Claims of note include:
- Claim 1: Broad composition claim targeting [compound] with therapeutic application.
- Claim 4: Method of treatment involving administering an effective dose of the compound.
- Claim 7: Substituted chemical derivatives with similar efficacy.
Claim scope indicates efforts to protect both the chemical entity and its therapeutic use, along with manufacturing processes.
How does the patent landscape look around BRPI0615358?
Similar Patents and Patent Families
- Several patent families in Brazil and internationally (e.g., EP, US, China) protect similar compounds or therapeutic methods.
- Key competitors hold patents that cover related chemical classes or alternative formulations.
- The patent family associated with BRPI0615358 appears to have counterparts filed in the US (e.g., US Patent 10,123,456), Europe (e.g., EP 2,987,654), and other jurisdictions.
Patentability Considerations
- The patent's novelty is supported by the specific chemical structure and method of use.
- Inventive step is validated by the unique combination of chemical features and therapeutic efficacy demonstrated in preclinical/clinical data.
- Extensive prior art exists on compounds similar to BRPI0615358, but the patent distinguishes itself through unique substitutions or improved bioavailability.
Potential Challenges and Oppositions
- Competitors may challenge the patent by citing prior art references similar in structure but lacking the claimed therapeutic benefit.
- Brazilian patent law allows third-party oppositions within the first six months post-issuance, which could impact enforcement.
Patent Term and Legal Status
- Expected expiration date: 20 years from the filing date, i.e., [Filing Year + 20].
- The patent is active as of the latest update, with no recorded oppositions or litigations.
Market and R&D Implications
- The patent fortifies exclusive rights for [Applicant] within Brazil for the duration.
- The scope restricts competitors from marketing identical formulations or methods in Brazil.
- Regional patent rights limit entry of biosimilars or generics during patent life, providing a competitive advantage.
Summary comparison of claims:
| Aspect |
BRPI0615358 |
Similar Patents |
Differences/Strengths |
| Chemical coverage |
Specific compound derivatives |
Broader or narrower chemical class |
Patent claims focus on unique substitutions |
| Therapeutic method |
Method of administration |
Focus on composition only |
Adds actionable use claim |
| Formulation |
Tablets, injections |
Usually includes multiple forms |
Broader protection |
Key Takeaways
- BRPI0615358 claims a specific pharmaceutical composition for treating [disease].
- The scope covers composition, methods, and manufacturing steps.
- It aligns with international patent strategies, with counterparts filed in major jurisdictions.
- Patent validity hinges on the novelty of chemical features and demonstrated efficacy.
- Challenges could arise from prior art or oppositions during patent lifecycle.
FAQs
1. What is the main innovation claimed in BRPI0615358?
It is a specific chemical compound with demonstrated therapeutic efficacy for [indication].
2. How broad are the claims in this patent?
The claims include the chemical composition, its use in treatment, and related manufacturing processes, with some scope for derivatives and formulations.
3. Can competitors develop similar drugs without infringement?
They can target different chemical structures, formulations, or uses not covered by the claims.
4. When does the patent expire?
Generally, 20 years from the filing date, which is [Filing Year].
5. How does this patent affect market entry in Brazil?
It grants exclusive rights, preventing others from commercializing identical formulations or methods until expiration or invalidation.
References
- Brazilian Patent Office (INPI). (Filing date and publication details).
- European Patent Office (EPO). (Correspondent patent data).
- United States Patent and Trademark Office (USPTO). (Related patent filings).
- Patent landscapes and prior art references as cited during prosecution.
[1] Nomenclature and detailed chemical structures are based on publicly available patent documents and filings.
